The mission of Center for ViroScience and Cure (CVC) is to develop therapeutic and curative strategies that improve the lives of the many who are battling acute, chronic and difficult-to-treat virus infections and related complications.
Our researchers have been highly successful in developing small molecules, from discovery to clinical use, for treating devastating human viral infections. Currently, our drug discovery efforts focus on the following areas:
- Anti-HIV/AIDS drugs targeting replication and various viral reservoirs
- Anti-HCV drugs targeting viral replication
- Anti-HBV drugs targeting viral replication
- Anti-SARS-CoV-2 small molecule inhibitors
- Anti-Monkeypox virus small molecule inhibitors
- Anti-Ebola virus drugs
- Anti-Zika virus drugs
- Anti-Influenza virus drugs
- Anti-Norovirus drugs targeting viral replication
- Anti-Dengue virus drugs targeting viral replication
- Anti-respiratory syncytial virus (RSV) drugs targeting viral replication
- Anti-cancer drugs
- Experimental models for chronic liver disease
Meet the Team
Raymond Schinazi, PhD, Hon D.Sc.
Senior Advisor of Center for ViroScience and Cure (CVC)
Stefan Sarafianos, PhD
Co-Director of Center for ViroScience and Cure (CVC)
